FEMY vs ICU

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

FEMY

33.4
AI Score
VS
ICU Wins

ICU

60.7
AI Score

Investment Advisor Scores

FEMY

33score
Recommendation
SELL

ICU

61score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric FEMY ICU Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -18.9% 82.0% ICU
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 33.4/100 60.7/100 ICU
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation SELL STRONG BUY ICU

Relative Price Performance (Last 90 Days)

FEMY 1M: +18.3% · 3M: -41.8% ICU 1M: -9.8% · 3M: +11.0%

Current Technical Phase

FEMY

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.1 · Price: $2.78

ICU

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.7%), weak momentum, RSI 43

RSI (14): 43.0 · Price: $3.03

Fundamentals Snapshot

Metric FEMY ICU
Market Cap
Forward P/E -1.3 -1.3
Trailing P/E
Revenue (TTM)
Revenue Growth -0.2% 0.8%
Gross Margin 0.6% 0.9%
Operating Margin -15.3% -6.2%
EPS -2.63 -1.89
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ICU is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.